Akshitha Thatiparthi, Amylee Martin, Jeffrey Liu, Alexander Egeberg, Jashin J Wu. Am J Clin Dermatol 2021
Times Cited: 15
Times Cited: 15
Times Cited
Times Co-cited
Similarity
20
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review.
April W Armstrong, Charlotte Read. JAMA 2020
April W Armstrong, Charlotte Read. JAMA 2020
20
Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors.
Keira A Fieldhouse, Samantha Ukaibe, Erika L Crowley, Reena Khanna, Ashley O'Toole, Melinda J Gooderham. Drugs Context 2020
Keira A Fieldhouse, Samantha Ukaibe, Erika L Crowley, Reena Khanna, Ashley O'Toole, Melinda J Gooderham. Drugs Context 2020
13
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1).
Craig L Leonardi, Alexa B Kimball, Kim A Papp, Newman Yeilding, Cynthia Guzzo, Yuhua Wang, Shu Li, Lisa T Dooley, Kenneth B Gordon. Lancet 2008
Craig L Leonardi, Alexa B Kimball, Kim A Papp, Newman Yeilding, Cynthia Guzzo, Yuhua Wang, Shu Li, Lisa T Dooley, Kenneth B Gordon. Lancet 2008
13
IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis.
Andrew Johnston, Xianying Xing, Liza Wolterink, Drew H Barnes, ZhiQiang Yin, Laura Reingold, J Michelle Kahlenberg, Paul W Harms, Johann E Gudjonsson. J Allergy Clin Immunol 2017
Andrew Johnston, Xianying Xing, Liza Wolterink, Drew H Barnes, ZhiQiang Yin, Laura Reingold, J Michelle Kahlenberg, Paul W Harms, Johann E Gudjonsson. J Allergy Clin Immunol 2017
13
Comparative risk of serious infections among real-world users of biologics for psoriasis or psoriatic arthritis.
Xintong Li, Kathleen M Andersen, Hsien-Yen Chang, Jeffrey R Curtis, G Caleb Alexander. Ann Rheum Dis 2020
Xintong Li, Kathleen M Andersen, Hsien-Yen Chang, Jeffrey R Curtis, G Caleb Alexander. Ann Rheum Dis 2020
13
IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications.
Esther von Stebut, Wolf-Henning Boehncke, Kamran Ghoreschi, Tommaso Gori, Ziya Kaya, Diamant Thaci, Andreas Schäffler. Front Immunol 2020
Esther von Stebut, Wolf-Henning Boehncke, Kamran Ghoreschi, Tommaso Gori, Ziya Kaya, Diamant Thaci, Andreas Schäffler. Front Immunol 2020
13
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial.
Eugene S Chung, Milton Packer, Kim Hung Lo, Adedigbo A Fasanmade, James T Willerson. Circulation 2003
Eugene S Chung, Milton Packer, Kim Hung Lo, Adedigbo A Fasanmade, James T Willerson. Circulation 2003
13
Treatment of Psoriasis With Biologic Therapy Is Associated With Improvement of Coronary Artery Plaque Lipid-Rich Necrotic Core: Results From a Prospective, Observational Study.
Harry Choi, Domingo E Uceda, Amit K Dey, Khaled M Abdelrahman, Milena Aksentijevich, Justin A Rodante, Youssef A Elnabawi, Aarthi Reddy, Andrew Keel, Julie Erb-Alvarez,[...]. Circ Cardiovasc Imaging 2020
Harry Choi, Domingo E Uceda, Amit K Dey, Khaled M Abdelrahman, Milena Aksentijevich, Justin A Rodante, Youssef A Elnabawi, Aarthi Reddy, Andrew Keel, Julie Erb-Alvarez,[...]. Circ Cardiovasc Imaging 2020
13
Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities.
Paolo Gisondi, Francesco Bellinato, Giampiero Girolomoni, Cristina Albanesi. Front Pharmacol 2020
Paolo Gisondi, Francesco Bellinato, Giampiero Girolomoni, Cristina Albanesi. Front Pharmacol 2020
13
Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study.
Youssef A Elnabawi, Amit K Dey, Aditya Goyal, Jacob W Groenendyk, Jonathan H Chung, Agastya D Belur, Justin Rodante, Charlotte L Harrington, Heather L Teague, Yvonne Baumer,[...]. Cardiovasc Res 2019
Youssef A Elnabawi, Amit K Dey, Aditya Goyal, Jacob W Groenendyk, Jonathan H Chung, Agastya D Belur, Justin Rodante, Charlotte L Harrington, Heather L Teague, Yvonne Baumer,[...]. Cardiovasc Res 2019
13
TNF Inhibitor-Induced Psoriasis: Proposed Algorithm for Treatment and Management.
Sara Jiayang Li, Lourdes M Perez-Chada, Joseph F Merola. J Psoriasis Psoriatic Arthritis 2019
Sara Jiayang Li, Lourdes M Perez-Chada, Joseph F Merola. J Psoriasis Psoriatic Arthritis 2019
13
Psoriasis and Co-morbidity.
Mina Amin, Erica B Lee, Tsen-Fang Tsai, Jashin J Wu. Acta Derm Venereol 2020
Mina Amin, Erica B Lee, Tsen-Fang Tsai, Jashin J Wu. Acta Derm Venereol 2020
13
Generalized pustular psoriasis treated with apremilast in a patient with multiple medical comorbidities.
Caleb Jeon, Mio Nakamura, Sahil Sekhon, Di Yan, Jashin J Wu, Wilson Liao, Tina Bhutani. JAAD Case Rep 2017
Caleb Jeon, Mio Nakamura, Sahil Sekhon, Di Yan, Jashin J Wu, Wilson Liao, Tina Bhutani. JAAD Case Rep 2017
13
Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data.
A Deodhar, P J Mease, I B McInnes, X Baraliakos, K Reich, A Blauvelt, C Leonardi, B Porter, A Das Gupta, A Widmer,[...]. Arthritis Res Ther 2019
A Deodhar, P J Mease, I B McInnes, X Baraliakos, K Reich, A Blauvelt, C Leonardi, B Porter, A Das Gupta, A Widmer,[...]. Arthritis Res Ther 2019
13
The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C.
H-Y Chiu, C-H Chen, M-S Wu, Y-P Cheng, T-F Tsai. Br J Dermatol 2013
H-Y Chiu, C-H Chen, M-S Wu, Y-P Cheng, T-F Tsai. Br J Dermatol 2013
13
Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial.
Kristian Reich, April W Armstrong, Richard G Langley, Susan Flavin, Bruce Randazzo, Shu Li, Ming-Chun Hsu, Patrick Branigan, Andrew Blauvelt. Lancet 2019
Kristian Reich, April W Armstrong, Richard G Langley, Susan Flavin, Bruce Randazzo, Shu Li, Ming-Chun Hsu, Patrick Branigan, Andrew Blauvelt. Lancet 2019
13
Long-term efficacy and safety of tildrakizumab for moderate-to-severe psoriasis: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2) through 148 weeks.
K Reich, R B Warren, L Iversen, L Puig, I Pau-Charles, A Igarashi, M Ohtsuki, M Falqués, M Harmut, S Rozzo,[...]. Br J Dermatol 2020
K Reich, R B Warren, L Iversen, L Puig, I Pau-Charles, A Igarashi, M Ohtsuki, M Falqués, M Harmut, S Rozzo,[...]. Br J Dermatol 2020
13
Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study.
Atul Deodhar, Alice B Gottlieb, Wolf-Henning Boehncke, Bin Dong, Yuhua Wang, Yanli Zhuang, William Barchuk, Xie L Xu, Elizabeth C Hsia. Lancet 2018
Atul Deodhar, Alice B Gottlieb, Wolf-Henning Boehncke, Bin Dong, Yuhua Wang, Yanli Zhuang, William Barchuk, Xie L Xu, Elizabeth C Hsia. Lancet 2018
13
Maintenance of clinical response and consistent safety profile with up to 3 years of continuous treatment with guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials.
Kristian Reich, Christopher E M Griffiths, Kenneth B Gordon, Kim A Papp, Michael Song, Bruce Randazzo, Shu Li, Yaung-Kaung Shen, Chenglong Han, Alexa B Kimball,[...]. J Am Acad Dermatol 2020
Kristian Reich, Christopher E M Griffiths, Kenneth B Gordon, Kim A Papp, Michael Song, Bruce Randazzo, Shu Li, Yaung-Kaung Shen, Chenglong Han, Alexa B Kimball,[...]. J Am Acad Dermatol 2020
13
Risk for hepatitis B and C virus reactivation in patients with psoriasis on biologic therapies: A retrospective cohort study and systematic review of the literature.
Igor Snast, Lihi Atzmony, Marius Braun, Emmilia Hodak, Lev Pavlovsky. J Am Acad Dermatol 2017
Igor Snast, Lihi Atzmony, Marius Braun, Emmilia Hodak, Lev Pavlovsky. J Am Acad Dermatol 2017
13
Safety Profile of Secukinumab in Treatment of Patients with Psoriasis and Concurrent Hepatitis B or C: A Multicentric Prospective Cohort Study.
Hsien-Yi Chiu, Rosaline Chung-Yee Hui, Yu-Huei Huang, Ruey-Yun Huang, Kai-Lung Chen, Ya-Chu Tsai, Po-Ju Lai, Ting-Shun Wang, Tsen-Fang Tsai. Acta Derm Venereol 2018
Hsien-Yi Chiu, Rosaline Chung-Yee Hui, Yu-Huei Huang, Ruey-Yun Huang, Kai-Lung Chen, Ya-Chu Tsai, Po-Ju Lai, Ting-Shun Wang, Tsen-Fang Tsai. Acta Derm Venereol 2018
13
Management of psoriatic patients in biologic treatment associated with infectious comorbidities.
Bernardini Nicoletta, Narcisi Alessandra, Skroza Nevena, Ersilia Tolino, Daniela Colapietra, Mastroianni Claudio, Potenza Concetta. Postepy Dermatol Alergol 2020
Bernardini Nicoletta, Narcisi Alessandra, Skroza Nevena, Ersilia Tolino, Daniela Colapietra, Mastroianni Claudio, Potenza Concetta. Postepy Dermatol Alergol 2020
100
Treatment of severe psoriasis with ixekizumab in a liver transplant recipient with concomitant hepatitis B virus infection.
Viviana Lora, Dario Graceffa, Catia De Felice, Aldo Morrone, Claudio Bonifati. Dermatol Ther 2019
Viviana Lora, Dario Graceffa, Catia De Felice, Aldo Morrone, Claudio Bonifati. Dermatol Ther 2019
20
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update.
C H Smith, Z Z N Yiu, T Bale, A D Burden, L C Coates, W Edwards, E MacMahon, S K Mahil, A McGuire, R Murphy,[...]. Br J Dermatol 2020
C H Smith, Z Z N Yiu, T Bale, A D Burden, L C Coates, W Edwards, E MacMahon, S K Mahil, A McGuire, R Murphy,[...]. Br J Dermatol 2020
13
Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials.
Kristian Reich, Kim A Papp, Andrew Blauvelt, Stephen K Tyring, Rodney Sinclair, Diamant Thaçi, Kristine Nograles, Anish Mehta, Nicole Cichanowitz, Qing Li,[...]. Lancet 2017
Kristian Reich, Kim A Papp, Andrew Blauvelt, Stephen K Tyring, Rodney Sinclair, Diamant Thaçi, Kristine Nograles, Anish Mehta, Nicole Cichanowitz, Qing Li,[...]. Lancet 2017
13
Risk of Hospitalization for Serious Infection After Initiation of Ustekinumab or Other Biologics in Patients With Psoriasis or Psoriatic Arthritis.
Yinzhu Jin, Hemin Lee, Moa P Lee, Joan E Landon, Joseph F Merola, Rishi J Desai, Seoyoung C Kim. Arthritis Care Res (Hoboken) 2021
Yinzhu Jin, Hemin Lee, Moa P Lee, Joan E Landon, Joseph F Merola, Rishi J Desai, Seoyoung C Kim. Arthritis Care Res (Hoboken) 2021
33
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.
Alan Menter, Bruce E Strober, Daniel H Kaplan, Dario Kivelevitch, Elizabeth Farley Prater, Benjamin Stoff, April W Armstrong, Cody Connor, Kelly M Cordoro, Dawn M R Davis,[...]. J Am Acad Dermatol 2019
Alan Menter, Bruce E Strober, Daniel H Kaplan, Dario Kivelevitch, Elizabeth Farley Prater, Benjamin Stoff, April W Armstrong, Cody Connor, Kelly M Cordoro, Dawn M R Davis,[...]. J Am Acad Dermatol 2019
13
Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin-17 inhibitors and their practical management.
D M Saunte, U Mrowietz, L Puig, C Zachariae. Br J Dermatol 2017
D M Saunte, U Mrowietz, L Puig, C Zachariae. Br J Dermatol 2017
13
Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study.
Xavier Mariette, Frauke Förger, Bincy Abraham, Ann D Flynn, Anna Moltó, René-Marc Flipo, Astrid van Tubergen, Laura Shaughnessy, Jeff Simpson, Marie Teil,[...]. Ann Rheum Dis 2018
Xavier Mariette, Frauke Förger, Bincy Abraham, Ann D Flynn, Anna Moltó, René-Marc Flipo, Astrid van Tubergen, Laura Shaughnessy, Jeff Simpson, Marie Teil,[...]. Ann Rheum Dis 2018
13
Etanercept treatment for children and adolescents with plaque psoriasis.
Amy S Paller, Elaine C Siegfried, Richard G Langley, Alice B Gottlieb, David Pariser, Ian Landells, Adelaide A Hebert, Lawrence F Eichenfield, Vaishali Patel, Kara Creamer,[...]. N Engl J Med 2008
Amy S Paller, Elaine C Siegfried, Richard G Langley, Alice B Gottlieb, David Pariser, Ian Landells, Adelaide A Hebert, Lawrence F Eichenfield, Vaishali Patel, Kara Creamer,[...]. N Engl J Med 2008
13
Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS study.
Ian Landells, Colleen Marano, Ming-Chun Hsu, Shu Li, Yaowei Zhu, Lawrence F Eichenfield, Peter H Hoeger, Alan Menter, Amy S Paller, Alain Taieb,[...]. J Am Acad Dermatol 2015
Ian Landells, Colleen Marano, Ming-Chun Hsu, Shu Li, Yaowei Zhu, Lawrence F Eichenfield, Peter H Hoeger, Alan Menter, Amy S Paller, Alain Taieb,[...]. J Am Acad Dermatol 2015
13
Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature.
E Andreadou, E Kemanetzoglou, Ch Brokalaki, M E Evangelopoulos, C Kilidireas, A Rombos, E Stamboulis. Case Rep Neurol Med 2013
E Andreadou, E Kemanetzoglou, Ch Brokalaki, M E Evangelopoulos, C Kilidireas, A Rombos, E Stamboulis. Case Rep Neurol Med 2013
6
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary.
Giulia Lavinia Fonti, Maria Sole Chimenti, Elisabetta Greco, Laura Boffa, Paola Conigliaro, Paola Triggianese, Roberto Perricone. Clin Exp Rheumatol 2021
Giulia Lavinia Fonti, Maria Sole Chimenti, Elisabetta Greco, Laura Boffa, Paola Conigliaro, Paola Triggianese, Roberto Perricone. Clin Exp Rheumatol 2021
50
Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease.
Reiko M Onishi, Sarah L Gaffen. Immunology 2010
Reiko M Onishi, Sarah L Gaffen. Immunology 2010
6
Infliximab-Associated Chronic Inflammatory Central Nervous System Disease and Peroneal Nerve Injury in a Psoriatic Patient Refractory to Treatment: Case Report with 10-Year Follow-Up.
Sandra C Signore, Birka Brauns, Gunther Schütze, Christoph P Dohm, Mathias Bähr, Rotraut Mössner, Pawel Kermer. Case Rep Neurol 2018
Sandra C Signore, Birka Brauns, Gunther Schütze, Christoph P Dohm, Mathias Bähr, Rotraut Mössner, Pawel Kermer. Case Rep Neurol 2018
33
Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors.
Andrew J Solomon, Rebecca I Spain, Michael C Kruer, Dennis Bourdette. Mult Scler 2011
Andrew J Solomon, Rebecca I Spain, Michael C Kruer, Dennis Bourdette. Mult Scler 2011
6
A narrative review of psoriasis and multiple sclerosis: links and risks.
Annika S Silfvast-Kaiser, Katie B Homan, Bobbak Mansouri. Psoriasis (Auckl) 2019
Annika S Silfvast-Kaiser, Katie B Homan, Bobbak Mansouri. Psoriasis (Auckl) 2019
9
A case of concomitant psoriasis and multiple sclerosis: Secukinumab and rituximab exert dichotomous effects in two autoimmune conditions.
Martin Diebold, Simon Müller, Tobias Derfuss, Bernhard F Décard. Mult Scler Relat Disord 2019
Martin Diebold, Simon Müller, Tobias Derfuss, Bernhard F Décard. Mult Scler Relat Disord 2019
11
Multiple sclerosis following anti-tumor necrosis factor-alpha therapy for psoriasis: first case in Italy?
Maddalena Napolitano, Nicola Balato, Fabio Ayala, Teresa Cirillo, Anna Balato. G Ital Dermatol Venereol 2018
Maddalena Napolitano, Nicola Balato, Fabio Ayala, Teresa Cirillo, Anna Balato. G Ital Dermatol Venereol 2018
50
Demyelination during tumour necrosis factor antagonist therapy for psoriasis: a case report and review of the literature.
Satveer K Mahil, Thomasin C Andrews, Charlotte Brierley, Jonathan N Barker, Catherine H Smith. J Dermatolog Treat 2013
Satveer K Mahil, Thomasin C Andrews, Charlotte Brierley, Jonathan N Barker, Catherine H Smith. J Dermatolog Treat 2013
6
Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review.
Masahiro Kamata, Yayoi Tada. Int J Mol Sci 2020
Masahiro Kamata, Yayoi Tada. Int J Mol Sci 2020
6
Acute transverse myelitis during treatment with etanercept for severe plaque psoriasis.
Juan Escalas, Nicole Knöpfel, Ana Martin-Santiago, Carmen Calles. J Am Acad Dermatol 2014
Juan Escalas, Nicole Knöpfel, Ana Martin-Santiago, Carmen Calles. J Am Acad Dermatol 2014
20
Demyelinating disease in a patient with psoriatic arthritis and family history of multiple sclerosis treated with infliximab.
Teresa Ruiz-Jimeno, Alejandra Carvajal, Cristina Mata, Elena Aurrecoechea. J Rheumatol 2006
Teresa Ruiz-Jimeno, Alejandra Carvajal, Cristina Mata, Elena Aurrecoechea. J Rheumatol 2006
6
Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events.
Amy Kunchok, Allen J Aksamit, John M Davis, Orhun H Kantarci, B Mark Keegan, Sean J Pittock, Brian G Weinshenker, Andrew McKeon. JAMA Neurol 2020
Amy Kunchok, Allen J Aksamit, John M Davis, Orhun H Kantarci, B Mark Keegan, Sean J Pittock, Brian G Weinshenker, Andrew McKeon. JAMA Neurol 2020
6
Extensive and severe CNS demyelination associated with golimumab therapy.
Elisabeth Maillart, Caroline Papeix, Charles Mellerio, Anne Bertrand, Catherine Lubetzki, Céline Louapre. J Neurol 2016
Elisabeth Maillart, Caroline Papeix, Charles Mellerio, Anne Bertrand, Catherine Lubetzki, Céline Louapre. J Neurol 2016
14
Demyelinating disease associated with use of etanercept in patients with seronegative spondyloarthropathies.
Stacy A Davis, Robert R Johnson, John W Pendleton. J Rheumatol 2008
Stacy A Davis, Robert R Johnson, John W Pendleton. J Rheumatol 2008
6
Cerebral MRI lesions and anti-tumor necrosis factor-alpha therapy.
Alexander Winkelmann, Robert Patejdl, Sabine Wagner, Reiner Benecke, Uwe Klaus Zettl. J Neurol 2008
Alexander Winkelmann, Robert Patejdl, Sabine Wagner, Reiner Benecke, Uwe Klaus Zettl. J Neurol 2008
6
Bilateral optic neuritis associated with the use of infliximab.
Jan O Aasly. Case Rep Ophthalmol Med 2011
Jan O Aasly. Case Rep Ophthalmol Med 2011
12
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.